PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 54 filers reported holding PDS BIOTECHNOLOGY CORP in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $644,355 | -45.3% | 127,595 | -45.5% | 0.00% | -33.3% |
| Q2 2023 | $1,177,754 | -67.5% | 234,146 | -60.3% | 0.00% | -70.0% |
| Q1 2023 | $3,622,658 | -44.7% | 589,050 | +18.6% | 0.01% | -52.4% |
| Q4 2022 | $6,553,391 | +639.7% | 496,469 | +66.5% | 0.02% | +600.0% |
| Q3 2022 | $886,000 | -45.0% | 298,212 | -32.5% | 0.00% | -40.0% |
| Q2 2022 | $1,612,000 | -38.5% | 441,511 | +4.2% | 0.01% | -37.5% |
| Q1 2022 | $2,622,000 | -32.9% | 423,571 | -12.2% | 0.01% | 0.0% |
| Q4 2021 | $3,906,000 | -31.1% | 482,166 | +26.6% | 0.01% | -38.5% |
| Q3 2021 | $5,673,000 | +554.3% | 380,742 | +450.9% | 0.01% | +550.0% |
| Q2 2021 | $867,000 | +3512.5% | 69,107 | +512.1% | 0.00% | – |
| Q4 2020 | $24,000 | – | 11,290 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 117,242 | $311,000 | 0.07% |
| Andesa Financial Management Inc. | 16,655 | $44,000 | 0.04% |
| Sofinnova Investments, Inc. | 142,635 | $378,000 | 0.03% |
| INSPIRION WEALTH ADVISORS, LLC | 22,875 | $61,000 | 0.02% |
| REGENTATLANTIC CAPITAL LLC | 15,753 | $42,000 | 0.00% |
| Ellis Investment Partners, LLC | 2,250 | $5,000 | 0.00% |
| tru Independence LLC | 500 | $0 | 0.00% |
| Renaissance Technologies | 120,269 | $319,000 | 0.00% |
| D. E. Shaw & Co., Inc. | 13,281 | $35,000 | 0.00% |
| VANGUARD GROUP INC | 36,206 | $96,000 | 0.00% |